Physician profile
Amy L Day
NPI 1164466173
$18,387.50
in general payments reported to CMS, 2019-2025
15 companies · $689 in 2025
The $689 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $13K · 2021: $3,018 · 2022: $1,049 · 2023: $44.89 · 2024: $175 · 2025: $689.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $830 · Education: $77.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $830.44 |
| Education | $77.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,572.47 | 2020-2025 | |
| Medtronic, INC. | $222.14 | 2021-2025 | Signia, Sonicision |
| Davol INC. | $137.24 | 2019-2024 | Phasix Mesh |
| Ethicon US, LLC | $136.03 | 2019 | |
| Mentor Worldwide LLC | $90.35 | 2025 | Artoura Breast Tissue Expander |
| Covidien LP | $37.07 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $36.41 | 2019 | |
| Histosonics, INC. | $35.08 | 2024 | |
| Sun Pharmaceutical Industries INC. | $24.50 | 2019 | |
| Seagen INC. | $17.97 | 2019 | |
| Genzyme Corporation | $17.79 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.11 | 2019 | |
| Convatec INC. | $16.67 | 2019 | |
| Rochester Medical Corporation | $15.21 | 2022 | |
| Medtronic USA, INC. | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Day listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.